Email ID
Password
Scrip   
Injectable Revatio approved in EU
11 January 2010
Katie McQue

The European Commission has approved Pfizer's intravenous formulation of its phosphodiesterase-5 (PDE5) inhibitor Revatio (sildenafil, also known as Viagra for the treatment of erectile dysfunction) for the treatment of pulmonary arterial hypertension (PAH).

The IV formulation is indicated...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36